Aytu BioPharma, Inc. ( AYTU) - Stock Earnings
AYTU Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 2.0 million USD | 13.9 million USD |
| 2025Q4 | -10.6 million USD | 15.2 million USD |
| 2026Q1 | -5.6 million USD | 12.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AYTU Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.1 million USD | 107.4 million USD |
| 2024 | -15.8 million USD | 65.2 million USD |
| 2025 | -13.6 million USD | 66.4 million USD |
| 2026 Est. | — | — |
AYTU
Price: $2.16
52 week price:
Earnings Per Share: -4.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 55600
Ebitda: -9.2 millionMarket Capitalization: 18.2 million